Edgewise Grants Inducement Equity to 2 New Hires at $38.90 Strike
Image
BOULDER – November 02, 2026 -- Edgewise Therapeutics (Nasdaq: EWTX) granted inducement stock options on 17,250 shares and restricted stock units covering 8,626 shares to two new non-executive employees on October 30, 2026.
Options carry a $38.90 exercise price set at the grant-date close
Each option has an exercise price of $38.90 per share, equal to Edgewise's closing share price on the grant date. The awards were made under the company's 2024 Inducement Equity Incentive Plan.
Options vest over four years, with a one-year cliff
Twenty-five percent of the shares under each option vest on the first anniversary of the employee's start date. The remainder vest in 1/48th monthly installments, subject to continued service.